NYSE$ATR

AptarGroup Inc. · Q4 2024 earnings

Q4 2024 earnings · · After market close · Investor relations

Briefing

Aptar reported strong Q4 results with net income surging 62% year-over-year, driven by increased demand in pharma and closures segments. Adjusted EPS rose 27% while core sales grew 2%.

Headline financials

Total Revenue

$848M

Previous: $838M+1.1%
EPS (adj)

$1.52

Previous: $1.21+25.6%
Total Core Sales Growth

4.0%

Previous: 2.0%+100.0%
Reported Sales Growth

24.0%

No prior period
Adjusted EBITDA Margin

23.0%

No prior period
Pharma Adjusted EBITDA Margin

35.7%

No prior period
Beauty Adjusted EBITDA Margin

12.4%

No prior period
Closures Adjusted EBITDA Margin

16.1%

No prior period
Reported Effective Tax Rate

13.1%

No prior period
Adjusted Effective Tax Rate

13.5%

No prior period
Capital Expenditures

-$70.5M

Previous: $81.1M-186.9%
Net Income

$101M

Previous: $62.2M+62.2%
Operating Income

$123M

Previous: $84.2M+46.6%
Gross Profit

$262M

Previous: $312M-16.1%

Revenue & EPS history

AptarGroup · Revenue · Quarterly

$848M

Q4 2024+1.1%vs Q4 2023
Beat estimate in 8 of 15 quarters(53%)
ActualEstimate

Revenue by segment

AptarGroup · $893M total across 3 segments · Q3 2023

  • Pharma
    $389M+13.3%
  • Beauty
    $324M-10.0%
  • Closures
    $180M+34.6%

Forward guidance

Aptar expects continued earnings growth in 2025, led by pharma, but anticipates foreign exchange headwinds and higher tax rates in Q1.

Tailwinds

  • Pharma segment expected to drive future growth
  • Proprietary drug delivery systems showing strong demand
  • Cost containment efforts improving margins
  • Strong cash flow generation supporting investments
  • Share repurchase authorization provides capital return flexibility

Headwinds

  • Stronger U.S. dollar causing currency headwinds
  • Higher tax rate expected in Q1 2025
  • Softer demand anticipated in certain end markets
  • Potential impact from geopolitical uncertainties
  • Economic volatility could affect consumer demand

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2024

Historical avgQ4 2024

+0.3%

Avg return

Earnings day

-0.1%

Avg return

5 days after

+1.2%

Avg return

30 days after

63%

43 / 68 earnings

Positive

+9.2%

Q4 2017

Best reaction

-9.0%

Q3 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-3.3%-0.8%-6.4%
Q4 2025+8.3%+12.9%+6.5%
Q3 2025-9.0%-7.1%+0.3%
Q1 2025+2.3%+2.1%+6.8%
Q4 2024-8.5%-9.4%-2.3%
Q3 2024+0.8%+0.6%+2.3%
Q2 2024+1.7%+1.1%+4.4%
Q1 2024+2.4%+3.1%+5.8%
Q4 2023+5.4%+3.1%+8.6%
Q3 2023+0.1%-0.9%+4.2%
Q2 2023+3.2%+2.1%+6.3%
Q1 2023+2.4%+4.1%-1.4%
Q4 2022+5.7%+4.2%+0.3%
Q3 2022+2.1%-1.9%+6.9%
Q2 2022+1.6%+0.5%-1.5%
Q1 2022+3.4%+2.5%-2.0%
Q4 2021+3.3%+3.8%+2.7%
Q3 2021-3.6%+1.7%+1.0%
Q2 2021-6.3%-6.6%-2.3%
Q1 2021-0.2%+2.6%-2.5%
Q4 2020-7.7%-10.4%-2.7%
Q3 2020+1.6%+6.4%+13.3%
Q2 2020-3.0%-0.2%-0.6%
Q1 2020-3.6%-4.1%+1.2%
Q4 2019-2.6%-7.0%-19.6%
Q3 2019-7.1%-8.9%-6.0%
Q2 2019-5.0%-5.4%-1.3%
Q1 2019+1.3%+2.3%+2.0%
Q4 2018+1.5%+0.0%+2.2%
Q3 2018+1.8%+2.1%+2.0%
Q2 2018+8.6%+8.1%+9.6%
Q1 2018+0.3%+0.4%+1.0%
Q4 2017+9.2%+11.8%+9.6%
Q3 2017-0.6%-1.6%-2.5%
Q2 2017-6.5%-6.3%-6.4%
Q1 2017+1.2%+1.1%+6.3%
Q4 2016+1.7%+0.4%+4.4%
Q3 2016-4.3%-7.4%-0.3%
Q2 2016-1.9%-3.9%-1.6%
Q1 2016-3.1%
Q4 2015-2.8%
Q3 2015+2.4%
Q2 2015+8.3%
Q1 2015+2.4%
Q4 2014+1.8%
Q3 2014+2.0%
Q2 2014-3.5%
Q1 2014-0.1%
Q4 2013+1.9%
Q3 2013+0.2%
Q2 2013-2.1%
Q1 2013-2.0%
Q4 2012-0.8%
Q3 2012-3.5%
Q2 2012+2.6%
Q1 2012+0.9%
Q4 2011+0.1%
Q3 2011+5.8%
Q2 2011-5.0%
Q1 2010+2.2%
Q1 2011+2.3%
Q4 2008+1.5%
Q4 2010+1.5%
Q3 2010+2.9%
Q3 2009+2.9%
Q4 2009+0.5%
Q2 2009+0.5%
Q2 2010+0.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro